Most Active InvestorsFind investorsPricing
Start for free
Start for free
Highbridge Capital Management logo

Highbridge Capital Management

North America, New York, United States, New York

Description

HCM is a global alternative investment management firm launched in 1992. Since its inception, the company has developed a diversified

Investor Profile

Highbridge Capital Management has backed more than 29 startups, with 1 new investments in the last 12 months alone. The firm has led 13 rounds, about 45% of its total and boasts 19 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Post Ipo Debt, Post Ipo Equity, Series Unknown rounds (top funding stages).
  • Majority of deals are located in United States, Switzerland, Israel.
  • Strong thematic focus on Biotechnology, Health Care, Pharmaceutical.
  • Led 1 rounds in the past year.

Stage Focus

  • Post Ipo Debt (48%)
  • Post Ipo Equity (17%)
  • Series Unknown (14%)
  • Private Equity (7%)
  • Convertible Note (3%)
  • Debt Financing (3%)
  • Series C (3%)
  • Series B (3%)

Country Focus

  • United States (52%)
  • Switzerland (14%)
  • Israel (14%)
  • United Kingdom (7%)
  • Belgium (7%)
  • Ireland (3%)
  • Australia (3%)

Industry Focus

  • Biotechnology
  • Health Care
  • Pharmaceutical
  • Manufacturing
  • Medical Device
  • Therapeutics
  • Software
  • Medical
  • Oncology
  • Life Science
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Highbridge Capital Management frequently co-invest with?

DC
Downsview Capital
North America, Illinois, United States, Deerfield
Co-Investments: 2
Iroquois Capital
Iroquois Capital
North America, Tennessee, United States, Nashville
Co-Investments: 5
Harbor View Advisors
Harbor View Advisors
North America, Florida, United States, Ponte Vedra Beach
Co-Investments: 2
NC
Nite Capital Management
North America, Illinois, United States, Libertyville
Co-Investments: 4
Clarion Capital Partners
Clarion Capital Partners
North America, New York, United States, New York
Co-Investments: 2
Alpha Capital
Alpha Capital
North America, Illinois, United States, Chicago
Co-Investments: 1
Bristol Capital Advisors
Bristol Capital Advisors
North America, California, United States, Los Angeles
Co-Investments: 2
ArmaVir Partners
ArmaVir Partners
North America, New York, United States, New York
Co-Investments: 1
DC
DKR Capital
North America, Connecticut, United States, Stamford
Co-Investments: 2
Whitebox Advisors
Whitebox Advisors
North America, Minnesota, United States, Minneapolis
Co-Investments: 3

What are some of recent deals done by Highbridge Capital Management?

BiolineRx

Jerusalem, Yerushalayim, Israel

BioLineRx is a late clinical-stage biopharmaceutical development company that focuses on oncology.

BiotechnologyMedical DeviceOncologyTherapeutics
Post Ipo EquityNov 21, 2024
Amount Raised: $9,000,000
Santhera Pharmaceuticals

Liestal, Basel-Landschaft, Switzerland

Santhera Pharmaceuticals develops and markets pharmaceutical products for the treatment of mitochondrial and neuromuscular diseases.

BiotechnologyHealth CarePharmaceutical
Post Ipo DebtJun 18, 2024
Amount Raised: $77,583,793
Mithra Pharmaceuticals SA

Liège, Liege, Belgium

Mithra Pharmaceuticals SA specializes in the development of women's health care products.

BiotechnologyHealth CarePharmaceutical
Post Ipo DebtFeb 5, 2024
Amount Raised: $21,000,000
NantHealth

Culver City, California, United States

NantHealth is a healthcare company providing an evidence-based platform for healthcare diagnostics.

Health CareHealth DiagnosticsHospitalMedicalTherapeutics
Post Ipo DebtMar 6, 2023
Amount Raised: $22,500,000
Invacare

Elyria, Ohio, United States

Invacare is a manufacturer and distributor of medical equipment used in non-acute care settings.

Health CareManufacturingMedical DeviceWellness
Post Ipo DebtDec 23, 2022
Amount Raised: $5,500,000
Invacare

Elyria, Ohio, United States

Invacare is a manufacturer and distributor of medical equipment used in non-acute care settings.

Health CareManufacturingMedical DeviceWellness
Post Ipo DebtOct 3, 2022
Amount Raised: $18,500,000
Gamida Cell

Jerusalem, Yerushalayim, Israel

Gamida Cell is a biopharmaceutical company developing advanced cell therapies for patients with blood cancers and hematologic diseases.

BiotechnologyHealth CareLife ScienceMedical DeviceTherapeutics
Post Ipo DebtSep 28, 2022
Amount Raised: $25,000,000
Mithra Pharmaceuticals SA

Liège, Liege, Belgium

Mithra Pharmaceuticals SA specializes in the development of women's health care products.

BiotechnologyHealth CarePharmaceutical
Post Ipo DebtAug 8, 2022
Amount Raised: $89,235,633
Starry

Boston, Massachusetts, United States

Starry is an internet company that creates easy-to-use Wi-Fi products and radical ways to get Internet service.

HardwareInternetNetwork HardwareWireless
Post Ipo DebtMar 29, 2022
Amount Raised: $150,000,000
CompoSecure

Somerset, New Jersey, United States

CompoSecure is designing and manufacturing of premium metal financial cards.

ConsultingManufacturingProduct Design
Post Ipo EquityDec 28, 2021
Amount Raised: $175,000,000
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Most Active Investors Find InvestorsNewsletterPricing

Free tools

Pre-Money and Post-Money Valuation Calculator